Article Information
History
- January 18, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Emil K. Gustavsson1,7,26,$,
- Jordan Follett2,7,$,
- Joanne Trinh3,7,$,
- Sandeep K. Barodia4,
- Raquel Real5,6,26,
- Zhiyong Liu4,
- Melissa Grant-Peters1,25,
- Jesse D. Fox7,
- Silke Appel-Cresswell8,
- A. Jon Stoessl8,
- Alex Rajput9,
- Ali H. Rajput9,
- Roland Auer10,
- Russel Tilney5,6,
- Marc Sturm11,
- Tobias B. Haack11,
- Suzanne Lesage12,
- Christelle Tesson12,
- Alexis Brice12,13,
- Carles Vilariño-Güell14,
- Mina Ryten1,15,26,
- Matthew S. Goldberg4,
- Andrew B. West16,
- Michele T. Hu17,
- Huw R. Morris5,6,26,
- Manu Sharma18,
- Ziv Gan-Or,
- Bedia Samanci19,20,21,22,
- Pawel Lis25,26,
- Teresa Tocino23,
- Rim Amouri24,
- Samia Ben Sassi24,
- Faycel Hentati24,
- Global Parkinson’s Genetics Program (GP2),
- Francesca Tonelli25,26,
- Dario R. Alessi25,26 and
- Matthew J. Farrer2,7,#
- 1Department of Genetics and Genomic Medicine, Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK
- 2McKnight Brain Institute, Department of Neurology, University of Florida, Gainesville, Florida, USA
- 3Institute of Neurogenetics, University of Lübeck, Ratzeburger Allee 160, Lübeck 23538, Germany
- 4Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL, USA
- 5Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK
- 6UCL Movement Disorders Centre, University College London, London WC1N 3BG, UK
- 7Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada
- 8Pacific Parkinson’s Research Centre, Djavad Mowafaghian Centre for Brain Health, Division of Neurology, University of British Columbia, Vancouver, BC, Canada
- 9Movement Disorders Program, Division of Neurology, University of Saskatchewan and Saskatchewan Health Authority, Saskatoon, SK, Canada
- 10Department of Pathology, University of Saskatchewan and Saskatchewan Health Authority, Saskatoon, SK, Canada
- 11Institute for Medical Genetics and Applied Genomics, University of Tübingen, Germany
- 12Sorbonne Université, Institut du Cerveau–Paris Brain Institute–ICM, Inserm, CNRS, Paris, France
- 13Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Département de Neurologie, Centre d’Investigation Clinique Neurosciences, DMU Neuroscience, Paris, France
- 14Department of Medical Genetics, University of British Columbia, Vancouver V6T 1Z3, Canada
- 15NIHR Great Ormond Street Hospital Biomedical Research Centre, University College London, London WC1N 1EH, UK
- 16Duke Center for Neurodegeneration and Neurotherapeutics, Department of Pharmacology and Cancer Biology, Duke University, 3 Genome Court, Durham 27710, North Carolina, USA
- 17Division of Neurology, Nuffield Department of Clinical Neurosciences, University of Oxford, UK
- 18Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Germany
- 19The Neuro (Montreal Neurological Institute-Hospital), Montreal, Quebec, Canada
- 20Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada
- 21Department of Human Genetics, McGill University, Montreal, Quebec, Canada
- 22Behavioural Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
- 23Queen Mary College, University of London, UK
- 24Service de Neurologie, Institut National de Neurologie, La Rabta, Tunis 1007, Tunisia
- 25MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK
- 26Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA
- ↵#Corresponding Author:
Matthew J. Farrer (m.farrer{at}ufl.edu)
↵$ Equal contribution
Posted January 18, 2024.
A pathogenic variant in RAB32 causes autosomal dominant Parkinson’s disease and activates LRRK2 kinase
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos